Alexis Peyroles is CEO of OSE Immunotherapeutics, a clinical-stage biotechnology company based in Nantes, France.
One of the greatest challenges for pre-commercial biotech companies is consistently generating capital necessary for operating costs and for R&D of new products that provide value to stakeholders, both for investors... Read more »
Sponsored · Video
A Fireside Chat with Biocom President & CEO Joe Panetta
BiocomSponsored · Whitepaper
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Eurofins DiscoverX© 2007-2021, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.